Published in Chin J Cancer Res on December 01, 2012
Diet components can suppress inflammation and reduce cancer risk. Nutr Res Pract (2014) 0.85
Walnuts have potential for cancer prevention and treatment in mice. J Nutr (2014) 0.82
Melatonin as a potential anticarcinogen for non-small-cell lung cancer. Oncotarget (2016) 0.80
Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells. Oncol Lett (2016) 0.80
The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injury. Oxid Med Cell Longev (2014) 0.78
Melatonin and Hippo Pathway: Is There Existing Cross-Talk? Int J Mol Sci (2017) 0.75
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med (1995) 26.60
VEGF as a key mediator of angiogenesis in cancer. Oncology (2005) 3.65
Melatonin: from basic research to cancer treatment clinics. J Clin Oncol (2002) 1.99
Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin (2010) 1.98
A review of the multiple actions of melatonin on the immune system. Endocrine (2005) 1.55
VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis. Br J Cancer (2008) 1.55
Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol (2003) 1.55
Angiogenesis in endocrine tumors. Endocr Rev (2003) 1.50
Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br J Cancer (2007) 1.23
Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci (2003) 1.12
Transcriptional anti-angiogenesis therapy of human pancreatic cancer. Cytokine Growth Factor Rev (2006) 1.08
Mechanisms of cancer inhibition by melatonin. J Pineal Res (2004) 1.06
Anti-angiogenesis therapy in pancreatic carcinoma. JOP (2006) 1.03
Melatonin modulates the expression of VEGF and HIF-1 alpha induced by CoCl2 in cultured cancer cells. J Pineal Res (2008) 1.00
Anti-angiogenic activity of melatonin in advanced cancer patients. Neuro Endocrinol Lett (2001) 1.00
Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis. Integr Cancer Ther (2009) 0.99
Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor. J Pineal Res (2011) 0.95
Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK-MEL-1 cells. J Pineal Res (2010) 0.95
Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res (2006) 0.92
cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells. FASEB J (2003) 0.92
Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells. J Pineal Res (2011) 0.91
Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression. J Pineal Res (2011) 0.89
Intracellular signaling pathways involved in cell growth inhibition of human umbilical vein endothelial cells by melatonin. J Pineal Res (2008) 0.88
High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res (2005) 0.87
Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis. Pancreas (2007) 0.87
Immunomodulatory effects of melatonin in asthma. Am J Respir Crit Care Med (2002) 0.85
Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein. Cancer Res (2010) 0.85
Effect and mechanism of melatonin's action on the proliferation of human umbilical vein endothelial cells. J Pineal Res (2006) 0.83
Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters. Med Oncol (2009) 0.80
Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro. Cancer Lett (2007) 0.79
Significance of phospho-vascular endothelial growth factor receptor-2 expression in pancreatic cancer. Cancer Sci (2010) 0.78
Oncostatic action of melatonin: facts and question marks. Neuro Endocrinol Lett (2002) 0.78
[Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis]. Zhonghua Yi Xue Za Zhi (2009) 0.77
Human dendritic cells: natural adjuvants in antitumor immunotherapy. Cytokines Cell Mol Ther (1998) 0.77
MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma. Int J Oncol (2013) 1.16
Effects of intestinal mucosal blood flow and motility on intestinal mucosa. World J Gastroenterol (2011) 0.86
High levels of EphA3 expression are associated with high invasive capacity and poor overall survival in hepatocellular carcinoma. Oncol Rep (2013) 0.82
Pig Liver Xenotransplantation: A Review of Progress Toward the Clinic. Transplantation (2016) 0.75
Gastroesophageal reflux in cirrhotic patients without esophageal varices. World J Gastroenterol (2011) 0.75
Neuroprotective effects of flax lignan against NMDA-induced neurotoxicity in vitro. CNS Neurosci Ther (2012) 0.75